drugset

drugset / Trial / NCT05369078

Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects

NCT05369078 ↗

Phase 1 Unknown 16 enrolled Newsoara Biopharma Co., Ltd.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to investigate Safety, tolerability and pharmacokinetics in Chinese healthy subjects.

Timeline

Start: 2021-12-01
Primary completion: 2022-05-31
Completion: 2022-05-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bexagliflozin	Small molecule	20 mg	Oral

Indications